相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The effect of colchicine on mortality outcome and duration of hospital stay in patients with COVID-19: A meta-analysis of randomized trials
Chia Siang Kow et al.
IMMUNITY INFLAMMATION AND DISEASE (2022)
Immunopathology of Hyperinflammation in COVID-19
Joshua N. Gustine et al.
AMERICAN JOURNAL OF PATHOLOGY (2021)
Risk factors for severe and critically ill COVID-19 patients: A review
Ya-dong Gao et al.
ALLERGY (2021)
Amyloid storm: acute kidney injury and massive proteinuria, rapidly progressing to end-stage kidney disease in AA amyloidosis of familial Mediterranean fever
Olga L. Kukuy et al.
RHEUMATOLOGY (2021)
Defining colchicine resistance/intolerance in patients with familial Mediterranean fever: a modified-Delphi consensus approach
Seza Ozen et al.
RHEUMATOLOGY (2021)
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry
Anja Strangfeld et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
COVID-19 and the human innate immune system
Joachim L. Schultze et al.
CELL (2021)
COVID-19 outcomes in patients with familial Mediterranean fever: a retrospective cohort study
Serdar Can Guven et al.
RHEUMATOLOGY INTERNATIONAL (2021)
Incidence and course of COVID-19 hospitalizations among patients with familial Mediterranean fever
Fadi Kharouf et al.
RHEUMATOLOGY (2021)
The impact of COVID-19 on familial Mediterranean fever: a nationwide study
Zafer Gunendi et al.
RHEUMATOLOGY INTERNATIONAL (2021)
COVID-19 Among Patients With Inflammatory Rheumatic Diseases
Sinem Nihal Esatoglu et al.
FRONTIERS IN IMMUNOLOGY (2021)
Clinical course of COVID-19 in a cohort of 342 familial Mediterranean fever patients with a long-term treatment by colchicine in a French endemic area
Rim Bourguiba et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Immune dysfunction in COVID-19 and judicious use of antirheumatic drugs for the treatment of hyperinflammation
Abdurrahman Tufan et al.
TURKISH JOURNAL OF MEDICAL SCIENCES (2021)
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Dawei Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Chuan Qin et al.
CLINICAL INFECTIOUS DISEASES (2020)
Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19
Yang Yang et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
On the Alert for Cytokine Storm: Immunopathology in COVID-19
Lauren A. Henderson et al.
ARTHRITIS & RHEUMATOLOGY (2020)
SARS-CoV-2 and ORF3a: Nonsynonymous Mutations, Functional Domains, and Viral Pathogenesis
Elio Issa et al.
MSYSTEMS (2020)
Targeting the NLRP3 Inflammasome in Severe COVID-19
Tracey L. Freeman et al.
FRONTIERS IN IMMUNOLOGY (2020)
Familial Mediterranean Fever and COVID-19: Friends or Foes?
Alessandro Stella et al.
FRONTIERS IN IMMUNOLOGY (2020)
Familial Mediterranean fever, from pathogenesis to treatment: a contemporary review
Abdurrahman Tufan et al.
TURKISH JOURNAL OF MEDICAL SCIENCES (2020)
Colchicine-Update on mechanisms of action and therapeutic uses
Ying Ying Leung et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2015)